Skip to content

#335-01 Silic Rub Isola Sleeve for Int #281-03 Siz

by Intermedics, Inc.

510(k) K853034

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK853034 Date25 Jul 1985ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DXY
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a silicone rubber isolation sleeve designed for use with implantable pacemaker pulse generators. It serves as a protective barrier to isolate components, ensuring electrical insulation and mechanical stability within the cardiovascular system.

The Silic Rub Isola Sleeve is supplied as a single-use, sterile component intended for sterile surgical environments. It is compatible with MRI settings and is authorised under FDA 510K clearance (K853034) for use with implantable pacemaker systems. Storage and handling must adhere to sterile medical device protocols.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Silic Rub Isola Sleeve, and how does it function within an implantable pacemaker system?

    The Silic Rub Isola Sleeve acts as a protective silicone rubber barrier specifically designed to isolate components of an implantable pacemaker pulse generator. Its main functions are to provide electrical insulation and mechanical stability, ensuring the device operates safely and reliably within the cardiovascular system. This helps prevent potential complications like electrical short circuits or mechanical failure.

  • Is this device intended for reuse, or is it meant to be used only once during a procedure?

    The Silic Rub Isola Sleeve is explicitly supplied as a single-use component, meaning it is intended for use in one surgical procedure only. This aligns with standard sterile medical device protocols to maintain patient safety and prevent contamination.

  • How should the Silic Rub Isola Sleeve be stored, and what precautions should be taken to ensure its integrity?

    Since it is a sterile medical device, the sleeve must be stored and handled according to sterile medical device protocols. This includes keeping it in its original packaging until use, protecting it from physical damage, and ensuring it remains uncontaminated. Proper storage conditions help preserve sterility and functionality before implantation.

  • Can this device be used in patients who require MRI scans, and how does it address compatibility concerns?

    Yes, the Silic Rub Isola Sleeve is explicitly designed to be compatible with MRI settings, meaning it can be safely used in patients who require magnetic resonance imaging. This feature is particularly important for pacemaker patients, as MRI compatibility reduces the risk of interference or damage to the device during scans.

  • What regulatory pathway was followed for this device, and what does that mean for its use in clinical practice?

    The Silic Rub Isola Sleeve was authorized through the FDA 510(k) clearance process (K853034) under a Traditional 510(k) pathway, with a decision classification of *Substantially Equivalent* to a predicate device. This means the FDA determined it meets the same safety and effectiveness requirements as a previously approved comparable device, ensuring it adheres to strict regulatory standards for use in implantable pacemaker systems.